IL1B and ductal breast carcinoma in situ: While there has been no reported causal role for inflammasomes and the IL-1/IL-1R axis in breast cancer progression, IL-1β level is higher in invasive ductal carcinoma compared with ductal carcinoma in situ (non-invasive) and associated with a more aggressive phenotype13.